Gapping down
In reaction to earnings/guidance:
- IAG -26.5%, LYFT -24.7%, TUP -21.1%, INFN -16.2%, HLF -13.7%, AKAM -13.3%, WK -12.1%, ANDE -10.6%, BFAM -10.6% (also to acquire Only About Children for $320 mln), RVLV -10.3%, EAT -10.3%, AMRN -9.9%, NVTA -8.8%, IDXX -8.8%, JCI -8.2%, FRSH -6.3%, CWH -6.1%, BGFV -5.9%, MTCH -5.8% (also CEO to step down; names new CEO), KAR -5.6%, RNR -5.3%, MASI -5.2%, WING -5.2%, MTW -5.1%, GTE -4.6%, NWN -4.6%, SPT -4.2%, CNDT -4.1%, HZNP -3.9%, SWKS -3.4%, EVOP -3.1%, APG -2.8%, YUM -2.7%, EQX -2.6%, JHG -2.6%, VRSK -2.3% (also names new chairperson), LL -2.1%, MRCY -1.9%, GNW -1.8%, CRK -1.7%, RACE -1.5%, MCY -1.3%, BWA -1.2%, PRU -1.1%
Other news:
- CNTB -30.9% (announces top-line results for Phase 2 trial for CBP-307)
- KZR -26.9% (announces topline results from PRESIDIO Phase 2 trial of zetomipzomib)
- DIDI -6% (SEC has made inquiries regarding its IPO)
- TRC -4.1% (files for $200 mln mixed securities shelf offering)
- PHAT -4% (FDA approves VOQUEZNA for H. pylori infection)
- PRPL -1.5% (names new COO)
Analyst comments:
- TEVA -3.8% (downgraded to Underweight from Neutral at Piper Sandler)
- CVNA -2.8% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- LEG -2% (downgraded to Mkt Perform from Outperform at Raymond James)